Skip to main content

Parkinson-Syndrom:Lebenserwartung und Lebensqualität — Realität versus Patientensicht

  • Conference paper
Morbus Parkinson

Zusammenfassung

Ein Parkinson-Syndrom ist eine progredient verlaufende Krankheit, die im Spät-stadium erhebliche Behinderungsgrade bewirken kann. Die prognostische Beurteilung eines individuellen Verlaufs ist schwierig, erfordert aber in jedem Fall zunächst eine exakte differenzialdiagnostische Einordnung. Die idiopathische Parkinsonkrankheit muss von anderen degenerativen Prozessen (ParkinsonPlus-Syndromen) abgegrenzt werden [8]. Diagnostische Kriterien für das Vorliegen einer idiopathischen Parkinsonkrankheit sind gut validiert (sog. Londonbrain-bank-Kriterien; siehe Tabelle 1). Auch für die häufigsten Parkinson-PlusSyndome (siehe Tabelle 2) liegen international akzeptierte Kriterien vor [29].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51: 745–752

    Article  PubMed  CAS  Google Scholar 

  2. Gilman S, Low P, Quinn N (1998) Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res 8: 359–362

    Article  PubMed  CAS  Google Scholar 

  3. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17: 427–442

    Article  PubMed  CAS  Google Scholar 

  4. Horowski R, Horowsk L, Vogel S, Poewe W, Kielhorn FW (1995) An essay on Wilhelm von Humboldt and the shaking palsy: first comprehensive description of Parkinson’s disease by a patient. Neurology 45: 565–568

    Article  PubMed  CAS  Google Scholar 

  5. Humboldt W von (1986) Briefe an eine Freundin. Lindner J (Hrsg) Verlag der Nation, Berlin

    Google Scholar 

  6. Jankovic J, Kapadia AS (2001) Funcional decline in Parkinson’s disease. Arch Neurol 58: 1611–1615

    Article  PubMed  CAS  Google Scholar 

  7. Kostic V, Przedborski S, Flaster E, Sternic N (1991) Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson’s disease. Neurology 41: 202–205

    Article  PubMed  CAS  Google Scholar 

  8. Lachenmayer L, Arning C, Reichmann H (2002) Frith-und Differenzialdiagnose der Parkinson-Syndrome. Nervenheilkunde 21: 38–45

    Google Scholar 

  9. Lakke JPWF (1996) Wilhelm von Humboldt and James Parkinson. An appraisal of observation and creativity. Parkinsonism and Related Disorders 2: 225–229

    Article  PubMed  CAS  Google Scholar 

  10. Leplow B (1998) Psychologische und psychosoziale Aspekte beim Parkinson-Syndrom. Psycho 24: 554–559

    Google Scholar 

  11. Litvan I, Agid Y, Caine D (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1–9

    Article  PubMed  CAS  Google Scholar 

  12. Martinez-Martin P, Valldeoriola F, Tolosa E, Pilleri M, Molinuevo, JL, Rumia J, Ferrer E (2002) Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson’s disease. Mov Disord 17: 372–377

    Article  PubMed  Google Scholar 

  13. McKeith IG, Galasko D, Kosaka K (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113–1124

    Article  PubMed  CAS  Google Scholar 

  14. McKeith IG, Perry EK, Perry RH (1999) Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Neurology 53: 902–905

    Article  PubMed  CAS  Google Scholar 

  15. Morrish P (2002) Is it time to abandon functional imaging in the study of neuroprotection? Mov Disord 17: 229–232

    Article  PubMed  Google Scholar 

  16. Muller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I (2000) Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 55: 888–891

    Article  PubMed  CAS  Google Scholar 

  17. Myslobodsky M, Lalonde FM, Hicks L (2001) Are patients with Parkinson’s disease suicidal? J Geriatr Psychiatry Neurol 14: 120–124

    Article  PubMed  CAS  Google Scholar 

  18. Olanow CW, Watts RL, Koller WC (2001) An algorithm (decision tree) for the management of Parkinson’s disease: treatment guidelines. Neurology 56 (Suppl 5)

    Google Scholar 

  19. Palmer CS, Schmier JK, Snyder E, Scott B (2000) Patient preferences and utilities for “off-time” outcomes in the treatment of Parkinson’s disease. Quality of Life Res 9: 819–827

    Article  CAS  Google Scholar 

  20. Parkinson Study Group (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. JAMA 284: 1931–1938

    Article  Google Scholar 

  21. Parkinson Study Group (2002) Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 287: 1653–1661

    Article  Google Scholar 

  22. Poewe W, Seppi K (2001) Treatment options for depression and psychosis in Parkinson’s disease. J Neurol 248 (Suppl 3): 12–21

    Article  Google Scholar 

  23. Poewe WH, Wenning GK (1996) The natural history of Parkinson’s disease. Neurology 47 (Suppl 3): S146–152

    Article  PubMed  CAS  Google Scholar 

  24. Pollak P, Fraix V, Krack P, Moro E, Mendes A, Chabardes S, Koudsie A, Benabid AL (2002) Treatment results: Parkinson’s disease. Mov Disord 17 (Suppl 3): S75–83

    Article  PubMed  Google Scholar 

  25. Rascol 0, Brooks DJ, Korczyn AD, DeDeyn PP, Clarke CE, Lang AE (2000) A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. NEJM 342: 1484–1491

    Article  PubMed  CAS  Google Scholar 

  26. Rascol 0, Goetz C, Koller W, Poewe W, Sampaio C (2002) Treatment interventions for Parkinson’s disease: an evidence based assessment. Lancet 359: 1589–1598

    Article  PubMed  Google Scholar 

  27. Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15: 1112–1118

    Article  PubMed  CAS  Google Scholar 

  28. Watts RL, Mirra SS, Richardson EP (1994) Corticobasal ganglionic degheneration. In: Marsden CD, Fahn S (eds) Movement Disorders. Butterworths-Heinemann, London

    Google Scholar 

  29. Wenning GK, Michlmayr S, Braune S, Brüke T, Fogel W, Gerster P, Schulz JB, Volkmann J (2001) Empfehlungen zur Differenzialdiagnose von Parkinson-Syndromen. Akt Neurol 28: 256–260

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lachenmayer, L. (2003). Parkinson-Syndrom:Lebenserwartung und Lebensqualität — Realität versus Patientensicht. In: Przuntek, H., Müller, T. (eds) Morbus Parkinson. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57362-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57362-0_5

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1422-5

  • Online ISBN: 978-3-642-57362-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics